Back to top

Analyst Blog

Alkermes plc (ALKS - Analyst Report) was a big mover last session, as the company saw its shares surge by about 8.5% on the day. The move came on solid volume too, with far more shares changing hands than in a normal session. This reverses the recent trend of the company, as the stock is now trading above the volatile price range of $30.17 to $35.21 in the past one-month time frame.

The company has seen no estimate revision in the past 2 months. Moreover, its earnings consensus has remained stagnant over the same time frame. However, this recent price action is certainly encouraging, so make sure to keep a close watch of this firm in the near future.

ALKS currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better performing med-biomed/gene stocks include Actelion Ltd. (ALIOF), AMAG Pharmaceuticals, Inc. (AMAG - Snapshot Report) and Gentium S.p.A . All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Please login to Zacks.com or register to post a comment.